- Orchard Therapeutics ( NASDAQ: ORTX ) said it plans to change the ratio of its American Depositary Shares to its ordinary shares, nominal value £0.10 per share, to a new ADS Ratio of one ADS to ten ordinary shares.
- The company expects the ADS ratio change to be effective on or about March 10.
- The change in the ADS Ratio will have the same effect as a one-for-ten reverse ADS split and is intended to enable the company to regain compliance with the Nasdaq minimum bid price requirement.
For further details see:
Orchard Therapeutics announces 1-for-10 ADS ratio change